Haematologica
(Mar 2017)
Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)
- Cyrille Touzeau,
- Steven Le Gouill,
- Béatrice Mahé,
- Jean Samuel Boudreault,
- Thomas Gastinne,
- Nicolas Blin,
- Hélène Caillon,
- Christelle Dousset,
- Martine Amiot,
- Philippe Moreau
Affiliations
- Cyrille Touzeau
- Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
- Steven Le Gouill
- Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
- Béatrice Mahé
- Department of Hematology, University Hospital, Nantes, France
- Jean Samuel Boudreault
- Department of Hematology, University Hospital, Nantes, France
- Thomas Gastinne
- Department of Hematology, University Hospital, Nantes, France
- Nicolas Blin
- Department of Hematology, University Hospital, Nantes, France
- Hélène Caillon
- Biochemistry Laboratory, University Hospital, Nantes, France
- Christelle Dousset
- Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
- Martine Amiot
- Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
- Philippe Moreau
- Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France
- DOI
-
https://doi.org/10.3324/haematol.2016.160408
- Journal volume & issue
-
Vol. 102,
no. 3
WeChat QR code
